Predictive intelligence for safer investment decisions
Snap 300 Atarax combines real-time data processing with predictive modeling to reduce uncertainty in investment decisions, without taking away the investor's final say on each choice.
Snap 300 Atarax combines real-time data processing with predictive modeling to reduce uncertainty in investment decisions, without taking away the investor's final say on each choice.
The system organizes extensive volumes of information into three complementary fronts, described without using unnecessary technical jargon.
Market indicators, trading volumes and historical series are collected and updated continuously, without lags that compromise the reading of the current scenario.
Statistical models identify patterns of variation before they consolidate into clear trends, allowing exposure adjustments earlier.
Each analysis cycle generates a structured record, documenting assumptions, variables considered and results, available for later consultation.
Concern about the opaque nature of automated systems is legitimate. Therefore, each step of the process is documented and can be consulted by the investor.
Market information, macroeconomic indicators and price history are consolidated into a single, continuously updated base.
Algorithms reduce statistical noise and isolate the variables with the greatest explanatory relevance regarding the behavior of the analyzed asset.
Scenarios are constructed from multiple hypotheses, each associated with an estimated probability of occurrence.
The results of the analysis reach the investor in a clear report, keeping the final decision under their responsibility.
Snap 300 Atarax consolidates tracked performance into a daily report, reducing the need for constant manual checks and delivering full visibility into relevant positions and variations.
The way in which analysis is used varies depending on the objective of those who monitor the data. Two frequent profiles illustrate this use.
When identifying a change in pattern in a monitored asset, the investor uses daily reports to assess whether the current exposure remains consistent with their strategy, adjusting positions before the variation intensifies.
With visibility over projected risk scenarios, those responsible for capital decisions distribute resources between alternatives more carefully, supporting strategic choices with measurable evidence.
Information travels encrypted and access to account records is restricted to the platform's own authentication processes. Market data used in the analysis is treated in aggregate form and does not identify third parties.
Performance reports are consolidated daily. The processing of market data that feeds the models occurs continuously throughout the day.
The models are periodically recalibrated based on new market data, comparing previous forecasts with observed results to adjust weights and variables considered.
The investor remains responsible for all allocation or rebalancing decisions. The platform delivers analyzes and scenarios; execution always depends on user evaluation.
Evaluate the methodology, daily reports, and modeling criteria before deciding how to use them in your strategy.
Access Snap 300 Atarax platformNo commitment to stay. Access may be interrupted at any time.